Medicinal products for the blood and blood-forming organs | Tenderlake

Medicinal products for the blood and blood-forming organs

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
25 January 2019
Closing Date:
26 February 2019
Location(s):
FRH BRETAGNE (FR FRANCE)
Description:

Provision of coagulation factor and other hemophilia drugs for the regional control group Bretagne "Blood-derived drugs - factors and other coagulation proteins."

PPSB (prothrombin complex)

PPSB (prothrombin complex).

Plasma factor VIII

Plasma factor VIII.

Factor VIII for minor, moderate and severe hemophilia, excluding prophylaxis

Factor VIII for minor, moderate and severe haemophilia, excluding prophylaxis.

Factor VIII - improved dosing regimen for severe hemophilia prophylaxis

Factor VIII - improved dosing regimen for severe haemophilia prophylaxis.

Factor VIII - improved dosage regimen for severe prophylaxis haemophilia, alternatively

Factor VIII - improved dosage regimen for severe haemophilia prophylaxis, as an alternative.

Non-Plasma Factor VIII Pediatric Indications

Non-plasma factor VIII pediatric indications.

Plasma von willebrand factor with or without associated factor Viii

Plasma von willebrand factor with or without associated Viii factor.

Von willebrand factor recombinant all assays

Von willebrand factor recombinant all assays.

Emcizumab

Emcizumab.

Human fibrinogen

Human fibrinogen.

Factor XI

Factor XI.

Factor XIII

Factor XIII.

Antithrombin III

Antithrombin III.

Active factor VII

Active factor VII.

Active prothrombinic complex

Active prothrombinic complex.

Plasma factor IX 1000 IU

Plasma factor IX 1000 IU.

IX factor half life extended

IX factor half life extended.

Download full details as .pdf
The Buyer:
Centre hospitalier régional et universitaire de Brest
CPV Code(s):
33621000 - Medicinal products for the blood and blood-forming organs